Clinical Trials for Rondo Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Rondo Therapeutics

Clinical Trials (1)

NCT07218003
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
PHASE1Not yet recruiting
149 participants
Started: Oct 27, 2025 · Completed: Mar 31, 2029
10 conditions1 sponsor2 locations